---
title: "Alemtuzumab - Relapsing Remitting Multiple Sclerosis"
sidebar: mydoc_sidebar
permalink: db00087-mesh-d020529-1.html
toc: false 
---


Path ID: `DB00087_MESH_D020529_1`
{% include image.html url="images/db00087-mesh-d020529-1.png" file="db00087-mesh-d020529-1.png" alt="db00087-mesh-d020529-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C096529 | alemtuzumab | Drug |
| UniProt:P31358 | CAMPATH-1 antigen | Protein |
| GO:0006959 | humoral immune response | BiologicalProcess |
| GO:0001788 | antibody-dependent cellular cytotoxicity | BiologicalProcess |
| GO:0008219 | Cell death | BiologicalProcess |
| CL:0001063 | tumor cell | Cell |
| MESH:D020529 | Relapsing remitting multiple sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Alemtuzumab | MOLECULARLY INTERACTS WITH | Campath-1 Antigen |
| Campath-1 Antigen | POSITIVELY REGULATES | Humoral Immune Response |
| Humoral Immune Response | POSITIVELY REGULATES | Antibody-Dependent Cellular Cytotoxicity |
| Antibody-Dependent Cellular Cytotoxicity | PRECEDES | Cell Death |
| Cell Death | DECREASES ABUNDANCE OF | Tumor Cell |
| Tumor Cell | MANIFESTATION OF | Relapsing Remitting Multiple Sclerosis |
|---------|-----------|---------|

Comment: NCIT:C38439 = mature lymphocytes could replace both B and T cell. Would have been an ideal node for this pair but could not be validated.

Reference: 
  - [https://go.drugbank.com/drugs/DB00087](https://go.drugbank.com/drugs/DB00087)
  - [https://en.wikipedia.org/wiki/Alemtuzumab](https://en.wikipedia.org/wiki/Alemtuzumab)
  - [https://en.wikipedia.org/wiki/Antibody-dependent_cellular_cytotoxicity](https://en.wikipedia.org/wiki/Antibody-dependent_cellular_cytotoxicity)
